HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Perfluorooctanesulfonyl fluoride

HCID 9388
New noteNew reactionRequest quotes
Print preview

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
307-35-7
Standard SMILES
O=S(=O)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
InChIKey
BHFJBHMTEDLICO-UHFFFAOYSA-N
Molecular formula
C8F18O2S
Average molar mass
502.12 g/mol
Monoisotopic mass
501.9331582

Overview

Perfluorooctylsulfonyl fluoride is a sulfonic acid derivative.

Names & identifiers

Preferred name
Perfluorooctanesulfonyl fluoride
IUPAC
1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonyl fluoride
English name
Perfluoro-1-octanesulfonyl fluoride
Molecular formula
C8F18O2S
Molecular weight
502.12

Names & synonyms

Perfluorooctanesulfonyl fluoride307-35-7PERFLUOROOCTYLSULFONYL FLUORIDEperfluorooctane sulfonyl fluorideHeptadecafluorooctanesulphonyl fluorideN-Perfluorooctanesulfonyl fluorideKPV81L86O0DTXSID50271401-Octanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-HEPTADECAFLUORO-1- OCTANESULFONYL FLUORIDERefChem:171671206-200-6
Show more names
posf1,1,2,2FX-8FC-850KG/DRUMFluorad FX-8xinjihuangsuanfuperfluorooctylfluoride
Perfluoro-1-octanesulfonyl fluoride1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonyl fluorideheptadecafluorooctane-1-sulfonyl fluorideMFCD00012016Perfluorooctylsulfonyl Fluoride (~90%)PFOSFC8F18O2SHSDB 5561

Database identifiers

Properties

Computed structural propertiesFilling in

XLogP
6
Topological polar surface area
42.5 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
20
Rotatable bonds
7
Heavy atoms
29
Formal charge
0
Complexity
724

Experimental & physicochemical properties

Chemical ClassesOther Classes -> Other Organic Compounds
PFAS · 6 items

PFAS

PFAS -> OECD Category

PFAS -> Perfluoroalkane sulfonyl fluoride (PASF)-based substances

PFAS -> Other/unspecified

PFAS -> Other/unspecified

PFAS -> Other/unspecified

Density1.824 g/mL at 25 °C
Color/FormLiquid
Boiling Point154 °C
Vapor Density>1 (Air = 1)
Physical DescriptionClear liquid; [MSDSonline]

Physicochemical properties

Melting point
-1 °C · -1 °C
Boiling point
154 · 154-155 °C(lit.)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Danger

H301 (47.4%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P260, P261, P264, P264+P265, P270, P271, P273, P280, P301+P316, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P318, P319, P321, P330, P363, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 78 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H301: Toxic if swallowed [Danger Acute toxicity, oral]

Hazard information

Regulatory Information · 4 items

Chemical: 1-Octanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-

S - indicates a substance that is identified in a final Significant New Use Rule.

Status: Cease Manufacture Update: 18-11-2010 https://echa.europa.eu/registration-dossier/-/registered-dossier/12501

Substance: Heptadecafluorooctanesulphonyl fluoride

Other Safety InformationIMAP assessments - Perfluorooctane sulfonate (PFOS) and its Direct Precursors: Human health tier II assessment
Hazards Summary · 1 item

Emergency treatment: Fluoride; [HSDB] Repeated high-dose studies have shown the liver to be the primary target organ; Effects observed in reproductive studies include increase in neonatal mortality; Multi-generational studies showed no effects to post-natal neurological development or to fertility in offspring; No evidence of mutagenicity; Perfluorooctanesulfonyl fluoride (POSF) based fluorochemicals can be absorbed into the body and metabolized into perfluorooctanesulfonate (PFOS); Monitoring of PFOS has been used to measure employee exposure to POSF based chemicals in manufacturing; [EPA] See Perfluorooctane sulfonic acid.

Chemistry & industry

Pharmacology

Absorption, Distribution and Excretion · 1 item

Perfluorooctanesulfonate and its salts (PFOS) are derived from perfluorooctanesulfonyl fluoride, the basic chemical building block for many sulfonyl-based fluorochemicals used as surfactants and for their repellent properties. PFOS is highly persistent in the environment and has a long serum elimination half-life in both animals and humans. ... Animal studies indicate that PFOS is well absorbed orally and distributes mainly in blood serum and the liver. ... /Perfluorooctanesulfonate, metabolite/

Uses & manufacturing

Uses · 3 items

Used as a precursor for various perfluorinated amides, alcohols, acrylates, and other fluorochemical polymers; [EPA]

Use as a surfactant, in paper and packaging treatment, and surface protectant

Precursor of many fluorinated sulfonyl surfactants

U.S. Production · 2 items

1-Octanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro- is listed as a High Production Volume (HPV) chemical (65FR81686). Chemicals listed as HPV were produced in or imported into the U.S. in >1 million pounds in 1990 and/or 1994. The HPV list is based on the 1990 Inventory Update Rule. (IUR) (40 CFR part 710 subpart B; 51FR21438).

Production volumes for non-confidential chemicals reported under the Inventory Update Rule.[Table#5436]

Use ClassificationPFAS (per- and polyfluoroalkyl substances) -> OECD Category
General Manufacturing Information1-Octanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-: ACTIVE

Applications

UsesPerfluorooctylsulfonyl Fluoride is commonly used as a surfactant for coatings such as papers and board coatings. As well, it can be commonly found to be used as a catalyst.

Related reactions

22 records
New reaction record
HRID 3954 reaction equation
HRID 3954As reactantuspto-grants-1988_02
HRID 96847 reaction equation
HRID 96847As reactantTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
HRID 208875 reaction equation
HRID 208875As reactantTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
HRID 315450 reaction equation
HRID 315450As reactantTraining data from https://doi.org/10.1039/C8SC04228D (8/10)
HRID 376220 reaction equation
HRID 376220As reactantuspto-grants-2000_02
HRID 567640 reaction equation
HRID 567640As reactantuspto-grants-2001_01
HRID 567641 reaction equation
HRID 567641As reactantuspto-grants-2001_01
HRID 567642 reaction equation
HRID 567642As reactantuspto-grants-2001_01
Page 1 of 3

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
CAS
307-35-7
PubChem CID
9388
DTXSID
DTXSID5027140
ChEBI
CHEBI:81538
UNII
KPV81L86O0
EC Number
206-200-6
Nikkaji
J57.758H
Density
1.824 g/mL · 1.824 g/mL at 25 °C(lit.)
vapor density
1 · >1 (vs air)
vapor pressure
10 mm · <10 mm Hg ( 20 °C)
refractive index
20 · n20/D 1.301
Flash point
100 °C · >100°C
solubility
Chloroform (Slightly), Methanol (Slightly)
form
liquid
color
colorless to yellow
Specific Gravity
1.81 · 1.81
Sensitive
Moisture Sensitive
BRN
1718067 · 1718067
Henry's Law Constant
1.5 · 1.5×10-7 mol/(m3Pa) at 25℃, HSDB (2015)
Stability
Hygroscopic, Moisture Sensitive
InChI
1S/C8F18O2S/c9-1(10,3(13,14)5(17,18)7(21,22)23)2(11,12)4(15,16)6(19,20)8(24,25)29(26,27)28
InChIKey
BHFJBHMTEDLICO-UHFFFAOYSA-N
SMILES
FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)S(F)(=O)=O
CAS DataBase Reference
307 · 307-35-7(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
81 L86O0 · KPV81L86O0
NIST Chemistry Reference
-1 · Perfluoro-1-octanesulfonyl fluoride(307-35-7)
EPA Substance Registry System
Perfluorooctylsulfonyl fluoride (307-35-7)
UNSPSC Code
12352100 · 12352100
NACRES
22 · NA.22
Symbol(GHS)
5 · GHS05
Signal word
Danger
Hazard statements
314 · H314
Precautionary statements
260 · P260-P264-P280-P301+P330+P331-P303+P361+P353-P363-P304+P340-P310-P305+P351+P338-P405-P501
PPE
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
Hazard Codes
C
Risk Statements
34 · 34
Safety Statements
26 · 26-36/37/39-45-25
RIDADR
3265 · UN 3265 8/PG 2
WGK Germany
3 · 3
F
10 · 10-21
Hazard Note
Corrosive
TSCA
TSCA listed
HazardClass
8 · 8
PackingGroup
II
HS Code
29041000 · 29041000
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
4 InhalationAcute · Acute Tox. 4 InhalationAcute Tox. 4 OralAquatic Chronic 2Carc. 2Lact.Repr. 1BSTOT RE 1
Hazardous Substances Data
307 · 307-35-7(Hazardous Substances Data)
REACH Registrations
Inactive
TSCA Requirements · 1 item

Certain perfluoroalkyl sulfonates. (a) Chemical substances and significant new uses subject to reporting. (1) The chemical substances listed in Table 1 /including 1-Octanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-/ ... of this section are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. ... (2) The significant new uses are: ... (ii) Any manufacture or import for any use of any chemical substance listed in Table 2 of paragraph (a)(1) of this section, except as noted in paragraph (a)(3) of this section. ... (3) Manufacture or import of any chemical substance listed in Table 2 ... for the following specific uses shall not be considered as a significant new use subject to reporting under this section: (i) Use as an anti-erosion additive in fire-resistant phosphate ester aviation hydraulic fluids. (ii) Use as a component of a photoresist substance, including a photo acid generator or surfactant, or as a component of an anti-reflective coating, used in a photomicrolithography process to produce semiconductors or similar components of electronic or other miniaturized devices. (iii) Use in coating for surface tension, static discharge, and adhesion control for analog and digital imaging films, papers, and printing plates, or as a surfactant in mixtures used to process imaging films. (iv) Use as an intermediate only to produce other chemical substances to be used solely for the uses listed in paragraph (a)(3)(i), (ii), or (iii) of this section.

Hazard Classes and Categories · 2 items

Acute Tox. 3 (47.4%)

Carcinogenicity - category 2

Safety & protection

Disposal Methods · 1 item

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal and plant life; and conformance with environmental and public health regulations.

Toxicology

Environmental Fate · 3 items

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 3.6X10+5(SRC), determined from a structure estimation method(2), indicates that perfluorooctylsulfonyl fluoride is expected to be immobile in soil(SRC). Volatilization of perfluorooctylsulfonyl fluoride from moist soil surfaces is expected to be an important fate process(SRC) given an estimated Henry's Law constant of 68 atm-cu m/mole(SRC), using a fragment constant estimation method(3). However, adsorption to soil is expected to attenuate volatilization(SRC). Perfluorooctylsulfonyl fluoride is expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 5.8 mm Hg at 25 °C(SRC), determined from a fragment constant method(4). Biodegradation data in soil were not available(2012, SRC).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 3.6X10+5(SRC), determined from a structure estimation method(2), indicates that perfluorooctylsulfonyl fluoride is expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is expected(3) based upon an estimated Henry's Law constant of 68 atm-cu m/mole(SRC), developed using a fragment constant estimation method(4). Using this Henry's Law constant and an estimation method(3), volatilization half-lives for a model river and model lake are 6.5 hours and 8.9 days, respectively(SRC). However, volatilization from water surfaces is expected to be attenuated by adsorption to suspended solids and sediment in the water column. The estimated volatilization half-life from a model pond is 845 years if adsorption is considered(5). According to a classification scheme(6), an estimated BCF of 5200(SRC), from an estimated log Kow of 7.84(7) and a regression-derived equation(8), suggests the potential for bioconcentration in aquatic organisms is very high(SRC). Biodegradation data in water were not available(2012, SRC). Perfluorooctylsulfonyl fluoride is expected to undergo hydrolysis in the environment due to the presence of functional groups that hydrolyze under environmental conditions(3). Perfluorooctylsulfonyl fluoride and perfluorooctylsulfonyl fluoride polymers ultimately degrade to perfluorooctane sulfonate(9).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), perfluorooctylsulfonyl fluoride, which has an estimated vapor pressure of 5.8 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase perfluorooctylsulfonyl fluoride is not expected to react with photochemically-produced hydroxyl radicals or be susceptible to direct photolysis by sunlight(SRC).

Adverse EffectsOccupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
Ecotoxicity Excerpts · 1 item

/AQUATIC SPECIES/ Perfluorinated surfactants (PFSs) in Asian freshwater fish species were analyzed to investigate tissue distribution, temporal trends, extent of pollution, and level of PFS exposure through food intake. Freshwater fish species, namely carp, snakehead, and catfish, were collected in Japan, Vietnam, India, Malaysia, and Thailand, and 10 PFSs, including perfluorooctanesulfonate (PFOS) and perfluorooctanoate, were analyzed by liquid chromatography-tandem mass spectrometry. PFSs in carp in Tokyo were more concentrated in kidneys (sum of 10 PFSs = 257 +/- 95 ng/g wet weight [ww]) and livers (119 +/- 36 ng/g ww) than in ovaries (43 +/- 2 ng/g ww) and muscles (24 +/- 17 ng/g ww). Concentrations of PFOS and its precursor, perfluorooctane sulfonamide, in livers of carp and in waters in Tokyo showed a dramatic decrease during the last decade, probably because of 3 M's phasing-out of the manufacture of perfluorooctanesulfonyl-fluoride-based products in 2000. In contrast, continuing contamination by long-chain perfluorocarboxylates (PFCAs) with > or =9 fluorinated carbons was seen in multiple media, suggesting that these compounds continue to be emitted. PFS concentrations in freshwater fish species in tropical Asian countries were generally lower than those in developed countries, such as Japan, e.g., for PFOS in muscle, Vietnam < 0.05-0.3 ng/g ww; India < 0.05-0.2 ng/g ww; Malaysia < 0.05-0.2 ng/g ww; Thailand < 0.05 ng/g ww; and Japan (Tokyo) = 5.1-22 ng/g ww. Daily intake of short-chain PFCAs with < or =8 fluorinated carbons from freshwater fish species in Japan was approximately one order of magnitude lower than that from drinking water, whereas daily intake of PFOS and long-chain PFCAs with > or =9 fluorinated carbons from freshwater fish species was comparable with or greater than that from drinking water. Because the risk posed by exposure to these compounds through intake of fish species is a matter of concern, we recommend the continued monitoring of PFS levels in Asian developing countries. /Perfluorinated surfactants/

Soil Adsorption/Mobility · 1 item

Using a structure estimation method based on molecular connectivity indices(1), the Koc of perfluorooctylsulfonyl fluoride can be estimated to be 3.6X10+5(SRC). According to a classification scheme(2), this estimated Koc value suggests that perfluorooctylsulfonyl fluoride is expected to be immobile in soil(SRC).

Human Toxicity Excerpts · 5 items

/EPIDEMIOLOGY STUDIES/ Workers with potential high exposure to Perfluorooctanesulfonyl Fluoride (POSF)-related compounds, including perfluorooctanesulfonate (PFOS), had 3 bladder cancer deaths vs. 0.2 expected (SMR 12.8; 95% CI 2.6 +/- 37.4). These compounds have not shown genotoxicity, and toxicology studies (including cancer bioassays) with PFOS and related sulfonamides have not shown bladder effects, but repeat-exposure data was not available for POSF. To further study the association of exposure to bladder cancer, we investigated ... bladder cancer incidence in workers. ... Because of high survivorship, living members (N = 1895) of the study were contacted by mail to answer a questionnaire about bladder cancer, and 74% participated. Validation occurred by medical record or death certificate for those original members deceased (N = 188). Incidence of bladder cancer was compared to expected based on NCI SEER data. Results: 11 bladder cancers were identified. The Standardized Incidence Ratio (SIR) for the entire cohort was 1.3 (95% CI 0.6 +/- 2.3). The SIR for ever working and working for more than one year in a high exposed job were 1.7 (95% CI 0.6 +/- 3.8) and 1.1 (95% CI 0.2 +/- 3.3), respectively. These studies do not support the hypothesis that the excess risk of bladder cancer initially reported was due to exposure to POSF-related materials or PFOS.

/EPIDEMIOLOGY STUDIES/ To determine whether bladder cancer is associated with exposure to perfluorooctane sulfonate (PFOS) in an occupational cohort /of perfluorooctanesulfonyl fluoride manufacturing workers./ Incidence of bladder cancer was ascertained by postal questionnaire to all living current and former employees of the facility (N = 1895) and death certificates for deceased workers (N = 188). Exposure to PFOS was estimated with work history records and weighted with biological monitoring data. Standardized incidence ratios (SIRs) were estimated using U.S. population-based rates as a reference. Bladder cancer risk within the cohort was evaluated using Poisson regression by cumulative PFOS exposure. Questionnaires were returned by 1,400 of the 1895 cohort members presumed alive. Eleven cases of primary bladder cancer were identified from the surveys (n = 6) and death certificates (n = 5). The SIRs were 1.28 (95% confidence interval [CI] = 0.64-2.29) for the entire cohort and 1.74 (95% CI = 0.64-3.79) for those ever working in a high exposed job. Compared with employees in the lowest cumulative exposure category, the relative risk of bladder cancer was 0.83 (95% CI = 0.15-4.65), 1.92 (95% CI = 0.30-12.06), and 1.52 (95% CI = 0.21-10.99). ... /Perfluorooctane sulfonate, metabolite/

/EPIDEMIOLOGY STUDIES/ The observed to expected episodes of care experience of 652 employees at a fluorochemical (perfluorooctanesulfonyl fluoride) production facility was compared with 659 film plant (nonfluorochemical) employees at the same site (Decatur, AL). Episodes of care were defined by a hierarchical analysis of health claims data from 1993 through 1998. The age- and sex-adjusted expected number of episodes of care was calculated from the company's U.S. manufacturing workforce. For a priori interests, the observed to expected episodes of care ratios were comparable for fluorochemical and film plant employees for liver tumors or diseases, bladder cancer, thyroid and lipid metabolism disorders, and reproductive, pregnancy, and perinatal disorders and higher for biliary tract disorders and cystitis recurrence. Non-a priori associations among the fluorochemical plant workers included benign colon polyps, malignant colorectal tumors, and malignant melanoma.

Artificial Pollution Sources · 1 item

Perfluorooctylsulfonyl fluoride's production and use as a surfactant, in paper and packaging treatment, and surface protectant(1) may result in its release to the environment through various waste streams(SRC). Perfluorooctylsulfonyl fluoride is also a precursor of many fluorinated sulfonyl surfactants(2).

Environmental BiodegradationBiodegradation data in soil or in water were not available. (2012, SRC)
Environmental Bioconcentration · 1 item

An estimated BCF of 5200 was calculated in fish for perfluorooctylsulfonyl fluoride(SRC), using an estimated log Kow of 7.84(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is very high(SRC).

Volatilization from Water/Soil · 1 item

The Henry's Law constant for perfluorooctylsulfonyl fluoride is estimated as 68 atm-cu m/mole(SRC) using a fragment constant estimation method(1). This Henry's Law constant indicates that perfluorooctylsulfonyl fluoride is expected to volatilize rapidly from water surfaces(2). Based on this Henry's Law constant, the volatilization half-life from a model river (1 m deep, flowing 1 m/sec, wind velocity of 3 m/sec)(2) is estimated as 6.5 hours(SRC). The volatilization half-life from a model lake (1 m deep, flowing 0.05 m/sec, wind velocity of 0.5 m/sec)(2) is estimated as 8.9 days(SRC). Perfluorooctylsulfonyl fluoride's Henry's Law constant indicates that volatilization from moist soil surfaces may occur(SRC). The volatilization half-life from a model pond is about 845 years when adsorption is considered(3). Perfluorooctylsulfonyl fluoride is expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 5.8 mm Hg(SRC), determined from a fragment constant method(4).

Non-Human Toxicity Excerpts · 1 item

/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ /The investigators/ investigated potential bladder effects of POSF in rats. ... Rats were exposed by inhalation to 0, 30, 100, or 300 ppm POSF 6 hrs/day, 5 days/week for 4 (0 and 300 ppm) or 13 weeks. Complete urinalysis was done on overnight urines. SEM/X-ray element analysis for crystals/calculi and immediate pH were conducted on fresh morning urines. Sagittal sections of urinary bladder were taken for SEM analysis and assessment of cell proliferation by proliferating cell nuclear antigen (3 sections, 103 cells/section). Results: There were no treatment-related findings with respect to urinalysis parameters, including pH and solids, nor changes of the urothelium, including no exposure-related increase in cell proliferation.

Environmental Abiotic Degradation · 1 item

Vapor-phase perfluorooctylsulfonyl fluoride is not expected to react with photochemically-produced hydroxyl radicals or be susceptible to direct photolysis by sunlight(SRC). Hydrolysis of perfluorooctylsulfonyl fluoride is expected due to the presence of functional groups that hydrolyze under environmental conditions(1). Perfluorooctylsulfonyl fluoride and perfluorooctylsulfonyl fluoride polymers ultimately degrade to perfluorooctane sulfonate(2).

Probable Routes of Human Exposure · 1 item

Occupational exposure to perfluorooctylsulfonyl fluoride may occur through inhalation and dermal contact with this compound at workplaces where perfluorooctylsulfonyl is produced or used(SRC). Studies have found perfluorooctylsulfonate chemicals in very small quantities in the blood of the general human population as well as in wildlife, indicating that exposure to the chemicals, including pristine environments, is widespread(1).

Regulatory information

TSCA Requirements · 1 item

Certain perfluoroalkyl sulfonates. (a) Chemical substances and significant new uses subject to reporting. (1) The chemical substances listed in Table 1 /including 1-Octanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-/ ... of this section are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. ... (2) The significant new uses are: ... (ii) Any manufacture or import for any use of any chemical substance listed in Table 2 of paragraph (a)(1) of this section, except as noted in paragraph (a)(3) of this section. ... (3) Manufacture or import of any chemical substance listed in Table 2 ... for the following specific uses shall not be considered as a significant new use subject to reporting under this section: (i) Use as an anti-erosion additive in fire-resistant phosphate ester aviation hydraulic fluids. (ii) Use as a component of a photoresist substance, including a photo acid generator or surfactant, or as a component of an anti-reflective coating, used in a photomicrolithography process to produce semiconductors or similar components of electronic or other miniaturized devices. (iii) Use in coating for surface tension, static discharge, and adhesion control for analog and digital imaging films, papers, and printing plates, or as a surfactant in mixtures used to process imaging films. (iv) Use as an intermediate only to produce other chemical substances to be used solely for the uses listed in paragraph (a)(3)(i), (ii), or (iii) of this section.

Safety data

F
10-21
PPE
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
wgk
3
tsca
TSCA listed
ridadr
UN 3265 8/PG 2
hs_code
29041000
risk_code
34
Signal word
Danger
Symbol(GHS)
GHS05
hazard_code
C
hazard_note
Corrosive
safety_code
26-36/37/39-45-25
hazard_class
8
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
II
Hazard statements
H314
REACH Registrations
Inactive
Hazard Classifications
Acute Tox. 4 InhalationAcute Tox. 4 OralAquatic Chronic 2Carc. 2Lact.Repr. 1BSTOT RE 1
Precautionary statements
P260-P264-P280-P301+P330+P331-P303+P361+P353-P363-P304+P340-P310-P305+P351+P338-P405-P501
Hazardous Substances Data
307-35-7(Hazardous Substances Data)

Upstream & downstream products

Upstream raw materials

1-octanesulphonyl fluorideThionane, 1,1-dioxidePerfluorooctanesulphonyl chlorideNonafluorobutanesulfonyl fluoride1-Octanesulfonyl ChlorideHydrogen fluoride3-Sulfolene

Downstream products

N-ethyl perfluorooctylsulfonylaminoacetate1-BroMoheptadecafluorooctaneMethyl perfluorooctanoateN-ethyl-N-[(heptadecafluorooctyl)sulphonyl]glycinePerfluorooctaneN-96%

Additional notes

DefinitionChEBI: Perfluorooctylsulfonyl fluoride is a sulfonic acid derivative.

/SURVEILLANCE/ Perfluorooctanesulfonyl fluoride (POSF, C8F17SO2F) concentrates in liver and serum and results in hypolipidemia as an early effect of cumulative dosages. Male and female employees of two perfluorooctanyl-manufacturing locations (Antwerp, Belgium and Decatur, Alabama) participated in a periodic medical surveillance program that included hematology, clinical chemistry, thyroid hormone, and urinalysis testing. Serum concentrations of PFOS and perfluorooctanoate (PFOA, C7F15CO2-, used as a fluoropolymer emulsifier) were measured via mass spectrometry methods. The mean serum PFOS and PFOA concentrations for 263 Decatur employees were 1.32 parts per million (ppm; geometric mean 0.91, range 0.06-10.06 ppm) and 1.78 ppm (geometric mean 1.13, range 0.04-12.70 ppm), respectively. Mean concentrations were approximately 50% lower among 255 Antwerp workers. Adjusting for potential confounding factors, there were no substantial changes in hematological, lipid, hepatic, thyroid, or urinary parameters consistent with the known toxicological effects of PFOS or PFOA in cross-sectional or longitudinal analyses of the workers' measured serum fluorochemical concentrations. /Perfluorooctane sulfonate, metabolite/

For more Human Toxicity Excerpts (Complete) data for PERFLUOROOCTYLSULFONYL FLUORIDE (10 total), please visit the HSDB record page.